BioSpace News Archive

Manitex Capital Inc. announces that its affiliate, Valeo Pharma Inc., has received approval from Health Canada for a new Parkinson’s Disease product ONSTRY® (safinamide) in Canada.

Proprietary Herbal Combination in OTC ‘Kamedis Calm’ to Receive Patent Protection

Mark Blecher, M.D. at Philadelphia Eye Associates in Philadelphia, Pa., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

In Addition, Almost Three-Quarters Are Interested In Viewing And Managing Health Care Benefits Using a Smartphone

JenaValve Technology, Inc., a developer, manufacturer and marketer of differentiated transcatheter aortic valve replacement (TAVR) systems for the treatment of aortic valve disease, today announced the appointment of veteran medical device executive John T. Kilcoyne as Chief Executive Officer, effective immediately.

Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of two new executives: Michael Aragon, M.D., who joins as Chief Medical Officer, and Stacey Porter, as Vice President, People Operations.

Mr. Watson is the founder of Pittencrieff Glen Associates, which he established in June of 1999.

Collaboration aims to develop first-in-class therapies for treatment resistant hospital acquired bacterial infections caused by Acinetobacter baumannii Infectious diseases are an area of interest of Boehringer Ingelheim’s Research Beyond Borders (RBB) department, which explores emerging science and technology beyond the company’s core areas of focus

After reviewing the application and supporting documentation, Health Canada granted an amended licence with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.

Popper and Co., a strategy consulting and transaction advisory firm guiding medical technology and life sciences companies working on the leading-edge of diagnostics and patient management, announced today the addition of Vincent Linder, PhD and Gene Vivino to its growing team of industry and clinical senior advisors.